• Users Online: 259
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 25  |  Issue : 3  |  Page : 99-103

Fibromyalgia, a disease or a subclinical presentation? A different perspective

1 Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Tanta University, Tanta, Egypt
2 Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Tanta University, Tanta, Egypt

Correspondence Address:
MD Shyma A Hablas
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Tanta University, Tanta, 31 111
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/kamj.kamj_29_19

Rights and Permissions

Context Fibromyalgia is a disease of exclusion. There is a huge overlap between symptoms of fibromyalgia and a lot of rheumatic, endocrinal, and metabolic diseases. Confirming the diagnosis of fibromyalgia might mask the diagnosis of a lot of conditions especially with the lack of periodic reevaluation to fibromyalgia patients. Objective The aim was to evaluate the diagnosis of fibromyalgia in unresponsive patients after more than a year of diagnosis. Patients and methods This is a cross-sectional observational study performed on 100 patients diagnosed with primary fibromyalgia for more than 1 year and that showed no response to two or three lines of treatments. Patients were investigated for erythrocyte sedimentation rate, rheumatoid factor, antinuclear antibody, in addition to serum vitamin D levels, total serum calcium, serum phosphorus, thyroid-stimulating hormone, parathormone hormone, and Dual energy Xray Absorptiometry (DEXA) scan. Patients were regrouped after laboratory investigations into two groups. Group I are patients who showed no abnormalities in their laboratory investigations. Group II are patients who showed abnormalities in their laboratory investigations. Functional assessment was performed for all patients by the fatigue assessment scale, insomnia severity index, and the visual analog scale for pain for patients in the beginning of the study and after 6 months. Results Less than 20% of the patients remained with no abnormality in their laboratory investigations, while about 80% showed laboratory abnormalities for other associated conditions. Conclusion Fibromyalgia patients showing response to treatment should be investigated on a regular basis even for markers that were shown to be normal. Treatment of any associated condition can improve symptoms of fibromyalgia dramatically.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded39    
    Comments [Add]    

Recommend this journal